|
NAA20 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.18159992480128E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.51969992145951E-10 |
| Normal-vs-Stage2 |
8.992000E-04 |
| Normal-vs-Stage3 |
1.09440234652425E-11 |
| Normal-vs-Stage4 |
2.09149999996772E-06 |
| Stage1-vs-Stage2 |
5.234800E-01 |
| Stage1-vs-Stage3 |
4.080000E-02 |
| Stage1-vs-Stage4 |
4.459200E-01 |
| Stage2-vs-Stage3 |
6.180300E-02 |
| Stage2-vs-Stage4 |
8.990600E-01 |
| Stage3-vs-Stage4 |
2.949900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.21510049086748E-10 |
| Normal-vs-AfricanAmerican |
9.70919999954134E-08 |
| Normal-vs-Asian |
3.805000E-04 |
| Caucasian-vs-AfricanAmerican |
9.110400E-01 |
| Caucasian-vs-Asian |
2.296400E-01 |
| AfricanAmerican-vs-Asian |
3.859600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.84270043668278E-10 |
| Normal-vs-Female |
1.36370026382338E-10 |
| Male-vs-Female |
5.326600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.835500E-04 |
| Normal-vs-Age(41-60Yrs) |
4.85030005048515E-09 |
| Normal-vs-Age(61-80Yrs) |
2.02119987413596E-10 |
| Normal-vs-Age(81-100Yrs) |
1.200980E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.742400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.852400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.424200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.881400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.099600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.016400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.805300E-04 |
| Normal-vs-Grade 2 |
3.00279999754238E-08 |
| Normal-vs-Grade 3 |
2.02493577461382E-12 |
| Normal-vs-Grade 4 |
8.21989998289752E-09 |
| Grade 1-vs-Grade 2 |
5.348800E-01 |
| Grade 1-vs-Grade 3 |
8.960800E-01 |
| Grade 1-vs-Grade 4 |
7.533600E-01 |
| Grade 2-vs-Grade 3 |
1.079750E-01 |
| Grade 2-vs-Grade 4 |
1.485350E-01 |
| Grade 3-vs-Grade 4 |
6.495600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.55010004621437E-09 |
| Normal-vs-ccB subtype |
7.27170545999911E-11 |
| ccA subtype-vs-ccB subtype |
1.279450E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.0112002608339E-10 |
| Normal-vs-N1 |
2.155200E-04 |
| N0-vs-N1 |
7.343400E-01 |
|
|
